WO2013128886A1 - Fluidic pump and network system - Google Patents

Fluidic pump and network system Download PDF

Info

Publication number
WO2013128886A1
WO2013128886A1 PCT/JP2013/001090 JP2013001090W WO2013128886A1 WO 2013128886 A1 WO2013128886 A1 WO 2013128886A1 JP 2013001090 W JP2013001090 W JP 2013001090W WO 2013128886 A1 WO2013128886 A1 WO 2013128886A1
Authority
WO
WIPO (PCT)
Prior art keywords
information
patient
liquid
medicine
medical treatment
Prior art date
Application number
PCT/JP2013/001090
Other languages
French (fr)
Japanese (ja)
Inventor
弘一郎 淺間
慎二 加藤
祥雄 榛葉
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Publication of WO2013128886A1 publication Critical patent/WO2013128886A1/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital

Definitions

  • the present invention relates to a liquid feed pump for feeding a medicine and a network system including the liquid feed pump.
  • liquid feeding pumps such as infusion pumps and syringe pumps are known as devices for delivering a medicine into a patient's body in a predetermined amount.
  • a medicine is delivered to a patient using a delivery pump
  • a user such as a nurse needs to set the kind of medicine and the delivery amount by manual input to the delivery pump in advance.
  • the liquid feed pump is provided with various configurations for preventing an erroneous operation by the user.
  • the liquid delivery amount set by the user is A configuration is provided for controlling so as not to exceed a limit value defined in the library.
  • the present invention has been made in view of the above problems, and an object of the present invention is to provide a system capable of performing management related to drug delivery in accordance with a patient's treatment stage.
  • a liquid feed pump has the following configuration. That is, A fluid delivery pump that can connect to a network and deliver medication to patients.
  • Storage means for storing a plurality of medical treatment schedules corresponding to each disease; An identifier indicating a medical treatment schedule currently applied to a patient who performs liquid feeding, and information indicating a current medical treatment stage of the patient performing the liquid feeding among the treatment stages in the medical treatment schedule via the network.
  • Receiving means for receiving An acquisition means for acquiring, from the medical treatment schedule stored in the storage means, the content of the medical treatment in the treatment stage corresponding to the information indicating the treatment stage included in the medical treatment schedule specified by the identifier; An extraction means for extracting information relating to the liquid delivery of the medicine included in the content of the acquired medical practice; Control means for controlling the liquid delivery pump based on information relating to the liquid delivery of the medicine extracted by the extraction means.
  • FIG. 1 is a diagram showing an overall configuration of a network system including a liquid feed pump according to an embodiment of the present invention.
  • FIG. 2 is a diagram illustrating an example of information managed in the patient management software, the clinical path management software, and the drug library management software.
  • FIG. 3A is a sequence diagram illustrating a flow of processing in the network system.
  • FIG. 3B is a sequence diagram illustrating a flow of processing in the network system.
  • FIG. 4 is a diagram showing a functional configuration of the liquid feed pump.
  • FIG. 5 is a flowchart showing the flow of an erroneous operation prevention process in the liquid feed pump.
  • FIG. 6A is a flowchart illustrating a flow of an erroneous operation prevention process in the liquid feed pump.
  • FIG. 6B is a flowchart showing the flow of an erroneous operation prevention process in the liquid feed pump.
  • FIG. 7 is a diagram showing an example of a medicine library display when an erroneous operation prevention process is executed.
  • FIG. 1 is a diagram showing the overall configuration of the network system 100.
  • reference numeral 110 denotes a first information processing apparatus in which medicine library management software 111 is installed.
  • the drug library information 112 can be generated, and new data can be added or changed to the generated drug library information 112.
  • FIG. 2a of FIG. 2 is a diagram illustrating an example of drug library information 112 generated by executing the drug library management software 111.
  • the drug library information 112 includes a drug name, a location (profile) where the drug is administered, a limit value (soft limit value, hard limit value) of the dose of the drug, and the like. Are stored in association with each other. It should be noted that each item shown in the drug library information 112 of 2a in FIG. 2 is an example, and it goes without saying that other items may be stored.
  • Reference numeral 120 denotes a second information processing apparatus in which clinical path management software 121 is installed.
  • the clinical path management software 121 is executed in the second information processing apparatus 120, the clinical path information 122 is displayed. Can be generated, or new data can be added to or changed from the generated clinical path information 122.
  • the clinical path is a medical treatment schedule handed to the patient at the time of admission.
  • the vertical axis indicates the content of medical actions (treatment items, test items, care items, etc.) necessary to cure the disease, and the time axis (date ) On the horizontal axis.
  • 2b of FIG. 2 is a diagram illustrating an example of clinical path information generated by executing the clinical path management software 121.
  • the clinical path information 122 includes a path ID (identifier) for identifying each clinical path and each treatment stage (“stage 1”, “stage 2”) in each clinical path.
  • Medical treatments ("inspection”, “surgery") performed on patients in Japan, drugs that are prohibited for use in performing each medical practice (prohibited drugs), or use is permitted but liquid delivery Information relating to medical practice such as a drug (restricted drug) whose limit value is strictly limited or its limit value is stored in association with each other.
  • Reference numeral 130 denotes a third information processing apparatus in which the patient management software 131 is installed.
  • the patient information 132 is generated by executing the patient management software 131 in the third information processing apparatus 130. Or adding / changing new data to the generated patient information 132.
  • 2c of FIG. 2 is a diagram illustrating an example of patient information 132 generated by executing the patient management software 131.
  • the patient information 132 stores the patient name, the disease name of the patient, the path ID of the clinical path applied to the patient, the current treatment stage of the patient, and the like in association with each other. Has been.
  • Reference numeral 150 denotes a mobile terminal that acquires patient information and information related to various medical devices such as a liquid feed pump used for treatment / examination, and transmits the information to the network 170 via the access point 160.
  • the first to third information processing devices (110, 120, 130), the syringe pump 140, and the access point 160 are connected to each other via the network 170.
  • patient information acquired in the mobile terminal 150 and information on various medical devices are transmitted to the first to third information processing devices (110, 120, 130), or the first to third information.
  • Various types of information stored in the processing devices (110, 120, 130) can be transmitted to the syringe pump 140.
  • FIG. 1 A block diagram showing a flow of processing in the network system 100.
  • step S331 the clinical path management software 121 is executed to generate a clinical path for each patient and register it as clinical path information 122.
  • step S332 the clinical path information 122 including a plurality of clinical paths generated for each patient in step S331 is transmitted to the syringe pump 140.
  • step S351 the syringe pump 140 to which the clinical path information 122 has been transmitted receives the clinical path information 122 and stores it in the internal storage device.
  • step S341 drug library information 112 is generated by executing the drug library management software 111.
  • step S342 the medicine library information 112 generated in step S341 is transmitted to the syringe pump 140.
  • step S352 the syringe pump 140 to which the drug library information 112 is transmitted receives the drug library information 112 and stores it in the internal storage device. In this manner, the clinical path information 122 and the drug library information 112 are stored in the syringe pump 140.
  • the network system 100 is used to administer a drug suitable for the current treatment stage in the currently applied clinical path to a predetermined patient.
  • the nurse or the like first inputs various information using the mobile terminal 150.
  • patient information of a patient who administers a drug is input.
  • the patient information may be input manually by a nurse or the like to the mobile terminal 150, or a tag attached to the patient (a tag on which patient information is recorded to identify the patient). ) May be read.
  • step S302 information related to a medical device used for drug administration is input.
  • the medical device information may be input manually by a nurse or the like to the mobile terminal 150 in the same manner as the patient information input, or a barcode (identified medical device) attached to the medical device.
  • the mobile terminal 150 may read a bar code indicating device information to be used).
  • step S303 when a nurse or the like inputs a transmission instruction to the mobile terminal 150, the patient information input in step S301 and the medical device information input in step S302 are transmitted via the network 170. And transmitted to the third information processing apparatus 130.
  • the path ID and the treatment stage information are acquired in step S311. Specifically, a path ID and treatment stage information corresponding to the received patient information are acquired from the patient information 132.
  • step S312 a medical device (syringe pump 140 in the present embodiment) corresponding to the received medical device information is specified, and the path ID and treatment stage information acquired in step S311 for the specified medical device. And send.
  • step S353 In the syringe pump 140 that has received the path ID and the treatment stage information, an erroneous operation prevention process is executed in step S353.
  • the updated drug library information is transmitted to the syringe pump 140, and the drug library information stored in the syringe pump 140 is updated. Updated.
  • the updated clinical path information is transmitted to the syringe pump 140, and the clinical path information stored in the syringe pump 140 is updated.
  • the syringe pump 140 can execute a malfunction prevention process suitable for the patient's treatment stage. Details of the malfunction prevention process in the syringe pump 140 will be described later.
  • FIG. 4 is a diagram illustrating the configuration of the syringe pump 140.
  • 401 is a control part, and controls the syringe pump 140 whole.
  • a memory 402 functions as a work area when various programs are executed in the control unit 401 and also functions as a temporary storage area for data used when various programs are executed.
  • Reference numeral 403 denotes a storage device, which stores a program 412 for realizing an erroneous operation preventing function described later, in addition to a program 411 for realizing a liquid feeding control function for feeding a medicine. Further, the medicine library information 112 transmitted from the first information processing apparatus 110 and the clinical path information 122 transmitted from the second information processing apparatus 120 are stored.
  • the program 411 for realizing the liquid feeding control function, the program 412 for realizing the erroneous operation prevention function, the drug library information 112 and the clinical path information 122 are appropriately stored in the memory 402 under the control of the control unit 401. , And executed or processed by the control unit 401.
  • Reference numeral 404 is an operation unit for inputting various instructions to the syringe pump 140.
  • Reference numeral 405 denotes a display unit that displays a processing result in the control unit 401.
  • Reference numeral 406 denotes a drive control unit that controls the operation of the drive unit 407 for feeding a medicine.
  • the drug library information 112 and the clinical path information 122 described above are received from the first information processing apparatus 110 or the second information processing apparatus 120 via the network I / F unit 408.
  • each part (401-408) which comprises the syringe pump 140 shall be mutually connected via the bus
  • FIG. 1 each part (401-408) which comprises the syringe pump 140 shall be mutually connected via the bus
  • the syringe pump 140 executes at least two types of erroneous operation prevention processes as the erroneous operation prevention process.
  • the first erroneous operation prevention process is a process for preventing an erroneous operation (an erroneous operation prevention process (1)) in the operation for designating the type of medicine to be fed on the syringe pump 140, and the second erroneous operation prevention.
  • the process is a process for preventing an erroneous operation (erroneous operation prevention process (2)) in an operation for setting a liquid supply amount when a specified medicine is supplied.
  • FIG. 5 is a flowchart showing the flow of an erroneous operation prevention process (1) for preventing an erroneous operation in an operation for designating the type of medicine to be delivered.
  • step S501 it is determined whether a medicine library display instruction has been accepted. If it is determined in step S501 that a medicine library display instruction has not been received, the process waits until a medicine library display instruction is received.
  • step S501 if it is determined in step S501 that a medicine library display instruction has been received, the process proceeds to step S502.
  • step S502 the drug library corresponding to the profile selected by the nurse or the like when the drug library is instructed to be displayed is read from the drug library.
  • step S503 the clinical path corresponding to the path ID transmitted from the third information processing apparatus 130 is read (in step S312).
  • step S504 information on the content of the medical practice corresponding to the treatment stage information transmitted from the third information processing apparatus 130 in step S312 is extracted from the clinical path read in step S502.
  • the path ID is “001” and the treatment stage information is information related to the content of the medical practice corresponding to “stage 1” (item: “examination”, prohibited drug: “drug A”. ", Restricted drug:” drug F ”) is extracted.
  • step S505 a prohibited drug contained in the extracted medical practice content is identified.
  • drug A is identified as a prohibited drug.
  • step S506 it is determined whether or not the prohibited drug identified in step S505 is included in the drug library read in step S502. If it is determined in step S506 that the prohibited drug is included in the read drug library, the process proceeds to step S507, and the prohibited drug is displayed in a shaded manner in displaying the drug library. indicate. Here, “medicine A” is shaded and the drug library is displayed.
  • FIG. 7 shows a state in which “medicine A” is displayed in a shaded manner by executing the erroneous operation prevention process (1) when a medicine library display instruction is input.
  • step S506 determines whether the prohibited drug is included in the drug library. If it is determined in step S506 that the prohibited drug is not included in the drug library, the process proceeds to step S508, and the drug library read in step S502 is displayed as it is.
  • FIG. 6A and 6B are flowcharts showing the flow of an erroneous operation prevention process (2) for preventing an erroneous operation in an operation for setting the liquid feeding amount.
  • step S601 the limit value corresponding to the medicine specified by the nurse or the like selected from the medicine library is read from the medicine library information 112.
  • the drug library information 112 defines a limit value for the liquid supply amount for each drug.
  • step S602 the limit value read in step S601 is set in the syringe pump 140.
  • step S603 the clinical path corresponding to the path ID transmitted from the third information processing apparatus 130 in step S312 is read.
  • step S604 the content of the medical practice corresponding to the treatment stage information transmitted from the third information processing apparatus 130 in step S312 is extracted from the clinical path read in step S603.
  • step S605 it is determined whether the content of the medical practice extracted in step S604 includes a drug whose limit value is limited (restricted drug).
  • the process proceeds to step S606.
  • step S606 the limit value of the restricted drug included in the extracted medical practice content is acquired.
  • step S607 the limit value set in step S602 is rewritten using the limit value acquired in step S606. Thereby, it is possible to set a higher limit value in accordance with the treatment stage than the limit value for each drug defined in the drug library information 112.
  • step S605 if it is determined in step S605 that the restricted medicine is not included in the content of the medical practice, the process proceeds to step S608. In this case, the limit value set in step S602 is maintained without being rewritten.
  • step S608 it is determined whether or not a liquid supply amount setting instruction has been input. If it is determined in step S608 that the liquid supply amount setting instruction has not been input, the process waits until it is input.
  • step S608 if it is determined in step S608 that the liquid supply amount setting instruction has been input, the process proceeds to step S609, and the input liquid supply amount setting instruction is set to the set limit value (the limit set in step S602). Value or the limit value rewritten in step S607).
  • step S609 If it is determined in step S609 that it is included within the range of the limit value, the process proceeds to step S610, and the input liquid supply amount setting instruction is accepted. On the other hand, if it is determined that it is not included in the limit value range, the process proceeds to step S611 to output an alarm.
  • the syringe pump 140 is configured to acquire and store clinical path information in addition to the drug library information. Furthermore, before delivering the drug to the patient, obtain the path ID indicating the clinical path applied to the patient and the current treatment stage information, and prohibit the use of the patient at the current treatment stage. It was set as the structure which acquires the limit value of the chemical
  • the first information processing device 110 to the third information processing device 130 are provided as separate bodies.
  • the present invention is not limited to this and is configured integrally. It goes without saying that it may be.
  • the first information processing apparatus 110 transmits the medicine library to the syringe pump 140 each time it is generated and updated.
  • the present invention is not limited to this.
  • it may be configured to transmit in response to a request from the syringe pump 140.
  • the request from the syringe pump 140 may be configured to be performed at regular intervals, or may be configured to be performed every time a specific operation is performed in the syringe pump 140.
  • the second information processing device 120 is configured to transmit the clinical path information to the syringe pump 140 each time it is generated and updated.
  • the present invention is not limited to this. .
  • it may be configured to transmit in response to a request from the syringe pump 140.
  • the request from the syringe pump 140 may be configured to be performed at regular intervals, or may be configured to be performed every time a specific operation is performed in the syringe pump 140.
  • the prohibited drug when displaying the drug library information in the syringe pump 140, the prohibited drug is displayed in a shaded manner.
  • the present invention is not limited to this.
  • it may be configured not to be displayed on the prohibited drug, or may be configured so that the prohibited drug cannot be selected (although it is displayed).
  • an alarm is output when the amount is outside the limit value range, but the present invention is not limited to this.
  • an operational restriction may be added so that setting exceeding the limit value cannot be performed.
  • the control in the case of setting the liquid delivery amount of the medicine in the syringe pump 140 has been described.
  • the present invention is not limited to this, and the same applies to settings other than the liquid delivery amount. You may comprise so that it may control based on a clinical path.
  • the erroneous operation prevention process (1) is executed in the operation for designating the type of medicine to be delivered, and the erroneous operation is prevented in the operation for setting the liquid delivery amount.
  • the process (2) is configured to be executed, the present invention is not limited to this, and only one of the erroneous operation prevention processes may be executed.
  • the erroneous operation prevention process (1) and the erroneous operation prevention process (2) are separately executed.
  • the present invention is not limited to this and is executed in parallel. It may be configured. In this case, the processing load of the syringe pump 140 can be reduced by executing the common processing only once.

Abstract

Provided is a system capable of managing the delivery of a drug solution according to the therapeutic stage of the patient. The present invention is a fluidic pump (140) that delivers a drug solution to a patient and is capable of being connected to a network (170), the fluidic pump being provided with: a storage means for storing a clinical path; a means for receiving via the network (170) an identifier that represents the clinical path currently being used for the patient to whom a solution is to be delivered and information representing the current therapeutic stage of the patient to whom said solution is to be delivered in said clinical path; a means for acquiring, from the stored clinical path, the details of the medical action corresponding to the information representing the therapeutic stage, the details being contained in the clinical path specified by the identifier; a means for extracting information relating to the delivery of the drug solution, the information being contained in the acquired details of the medical action; and a means for controlling the fluidic pump on the basis of the extracted information relating to the delivery of the drug solution.

Description

送液ポンプ及びネットワークシステムLiquid feed pump and network system
　本発明は、薬剤を送液する送液ポンプ及び該送液ポンプを含むネットワークシステムに関するものである。 The present invention relates to a liquid feed pump for feeding a medicine and a network system including the liquid feed pump.
　従来より、薬剤を所定送液量で患者の体内に送液するための装置として、輸液ポンプやシリンジポンプ等の送液ポンプが知られている。一般に、送液ポンプを用いて患者に薬剤を送液するにあたっては、看護師等の使用者が、事前に薬剤の種類や送液量を当該送液ポンプに手入力により設定する必要がある。しかしながら、使用者がこれらの設定を誤って入力してしまうと、患者に対して重大な影響を及ぼすこととなる。このため、従来より、送液ポンプには、使用者による誤操作を防止するための種々の構成が備えられている。 2. Description of the Related Art Conventionally, liquid feeding pumps such as infusion pumps and syringe pumps are known as devices for delivering a medicine into a patient's body in a predetermined amount. In general, when a medicine is delivered to a patient using a delivery pump, a user such as a nurse needs to set the kind of medicine and the delivery amount by manual input to the delivery pump in advance. However, if the user enters these settings incorrectly, it will have a significant impact on the patient. For this reason, conventionally, the liquid feed pump is provided with various configurations for preventing an erroneous operation by the user.
　例えば、薬剤の種類ごとに、送液量のリミット値をはじめとする各種情報が規定されたテーブル（薬剤ライブラリ）が格納された送液ポンプでは、使用者が設定する送液量が、当該薬剤ライブラリにおいて規定されたリミット値を超えることがないよう制御する構成が備えられている。 For example, in a liquid delivery pump that stores a table (medicine library) in which various types of information including a liquid delivery amount limit value are defined for each type of medicine, the liquid delivery amount set by the user is A configuration is provided for controlling so as not to exceed a limit value defined in the library.
特表２０１１－５０６０４８号公報Special table 2011-5006048 gazette
　しかしながら、薬剤ライブラリのように薬剤の種類ごとに一律にリミット値が規定されたテーブルを用いた場合、明らかな過剰投与等を防ぐことは可能であるが、患者に術後の治療を施す場合のように、治療段階ごとに送液すべき薬剤の送液量が高度に管理される必要がある状況下では、必ずしも有効といえない。更に、治療段階によっては使用が禁止されている薬剤を誤って選択してしまうといった誤操作を防ぐことも困難である。 However, when using a table in which limit values are uniformly defined for each type of drug, such as a drug library, it is possible to prevent obvious overdose, but in cases where patients are treated after surgery. Thus, it is not necessarily effective in a situation where it is necessary to highly control the amount of medicine to be delivered at each treatment stage. Furthermore, it is difficult to prevent erroneous operations such as erroneously selecting a drug prohibited to be used depending on the treatment stage.
　このようなことから、送液ポンプにおいて薬剤の種類や送液量等を管理するにあたっては、患者の治療段階に則した管理ができる構成とすることが望ましい。 For this reason, it is desirable to have a configuration that allows management in accordance with the patient's treatment stage when managing the type of drug and the amount of liquid delivered in the liquid delivery pump.
　本発明は上記課題に鑑みてなされたものであり、薬剤の送液に関する管理を、患者の治療段階に則して行うことが可能なシステムを提供することを目的とする。 The present invention has been made in view of the above problems, and an object of the present invention is to provide a system capable of performing management related to drug delivery in accordance with a patient's treatment stage.
　上記の目的を達成するために、本発明に係る送液ポンプは以下のような構成を備える。即ち、
　患者に対して薬剤の送液を行う、ネットワークに接続可能な送液ポンプであって、
　各疾病に応じた複数の診療スケジュールを記憶する記憶手段と、
　送液を行う患者に現在適用されている診療スケジュールを示す識別子と、該診療スケジュールにおける各治療段階のうち、該送液を行う患者の現在の治療段階を示す情報とを、前記ネットワークを介して受信する受信手段と、
　前記識別子により特定された診療スケジュールに含まれる、前記治療段階を示す情報に対応する治療段階における医療行為の内容を、前記記憶手段に記憶されている診療スケジュールより取得する取得手段と、
　前記取得された医療行為の内容に含まれる、薬剤の送液に関する情報を抽出する抽出手段と、
　前記抽出手段により抽出された前記薬剤の送液に関する情報に基づいて、前記送液ポンプを制御する制御手段とを備える。 In order to achieve the above object, a liquid feed pump according to the present invention has the following configuration. That is,
A fluid delivery pump that can connect to a network and deliver medication to patients.
Storage means for storing a plurality of medical treatment schedules corresponding to each disease;
An identifier indicating a medical treatment schedule currently applied to a patient who performs liquid feeding, and information indicating a current medical treatment stage of the patient performing the liquid feeding among the treatment stages in the medical treatment schedule via the network. Receiving means for receiving;
An acquisition means for acquiring, from the medical treatment schedule stored in the storage means, the content of the medical treatment in the treatment stage corresponding to the information indicating the treatment stage included in the medical treatment schedule specified by the identifier;
An extraction means for extracting information relating to the liquid delivery of the medicine included in the content of the acquired medical practice;
Control means for controlling the liquid delivery pump based on information relating to the liquid delivery of the medicine extracted by the extraction means.
　本発明によれば、薬剤の送液に関する管理を、患者の治療段階に則して行うことが可能なシステムを提供することができる。 According to the present invention, it is possible to provide a system capable of performing management related to drug delivery according to a patient's treatment stage.
　本発明のその他の特徴及び利点は、添付図面を参照とした以下の説明により明らかになるであろう。なお、添付図面においては、同じ若しくは同様の構成には、同じ参照番号を付す。 Other features and advantages of the present invention will become apparent from the following description with reference to the accompanying drawings. In the accompanying drawings, the same or similar components are denoted by the same reference numerals.
　添付図面は明細書に含まれ、その一部を構成し、本発明の実施の形態を示し、その記述と共に本発明の原理を説明するために用いられる。
図１は、本発明の一実施形態にかかる送液ポンプを含むネットワークシステムの全体構成を示す図である。 図２は、患者管理用ソフトウェア、クリニカルパス管理用ソフトウェア、及び、薬剤ライブラリ管理用ソフトウェアにおいてそれぞれ管理される情報の一例を示す図である。 図３Ａは、ネットワークシステムにおける処理の流れを示すシーケンス図である。 図３Ｂは、ネットワークシステムにおける処理の流れを示すシーケンス図である。 図４は、送液ポンプの機能構成を示す図である。 図５は、送液ポンプにおける誤操作防止処理の流れを示すフローチャートである。 図６Ａは、送液ポンプにおける誤操作防止処理の流れを示すフローチャートである。 図６Ｂは、送液ポンプにおける誤操作防止処理の流れを示すフローチャートである。 図７は、誤操作防止処理が実行された場合の、薬剤ライブラリの表示の一例を示す図である。 The accompanying drawings are included in the specification, constitute a part thereof, show an embodiment of the present invention, and are used to explain the principle of the present invention together with the description.
FIG. 1 is a diagram showing an overall configuration of a network system including a liquid feed pump according to an embodiment of the present invention. FIG. 2 is a diagram illustrating an example of information managed in the patient management software, the clinical path management software, and the drug library management software. FIG. 3A is a sequence diagram illustrating a flow of processing in the network system. FIG. 3B is a sequence diagram illustrating a flow of processing in the network system. FIG. 4 is a diagram showing a functional configuration of the liquid feed pump. FIG. 5 is a flowchart showing the flow of an erroneous operation prevention process in the liquid feed pump. FIG. 6A is a flowchart illustrating a flow of an erroneous operation prevention process in the liquid feed pump. FIG. 6B is a flowchart showing the flow of an erroneous operation prevention process in the liquid feed pump. FIG. 7 is a diagram showing an example of a medicine library display when an erroneous operation prevention process is executed.
　以下、必要に応じて添付図面を参照しながら本発明の各実施形態の詳細を説明する。なお、本発明は以下の実施形態に限定されるものではなく、適宜変更可能であるものとする。 Hereinafter, details of each embodiment of the present invention will be described with reference to the accompanying drawings as necessary. In addition, this invention is not limited to the following embodiment, It shall change suitably.
　［第１の実施形態］
　＜１．ネットワークシステムの全体構成＞
　はじめに本実施形態に係る送液ポンプを含むネットワークシステムの全体構成について説明する。図１はネットワークシステム１００の全体構成を示す図である。図１において、１１０は薬剤ライブラリ管理用のソフトウェア１１１がインストールされた第１の情報処理装置であり、当該第１の情報処理装置１１０により、薬剤ライブラリ管理用のソフトウェア１１１が実行されることにより、薬剤ライブラリ情報１１２を生成したり、生成した薬剤ライブラリ情報１１２への新たなデータの追加、変更等を行ったりすることができる。 [First Embodiment]
<1. Overall configuration of network system>
First, an overall configuration of a network system including a liquid feed pump according to the present embodiment will be described. FIG. 1 is a diagram showing the overall configuration of the network system 100. In FIG. 1, reference numeral 110 denotes a first information processing apparatus in which medicine library management software 111 is installed. When the medicine library management software 111 is executed by the first information processing apparatus 110, The drug library information 112 can be generated, and new data can be added or changed to the generated drug library information 112.
　図２の２ａは、薬剤ライブラリ管理用のソフトウェア１１１が実行されることにより生成された薬剤ライブラリ情報１１２の一例を示す図である。図２の２ａに示すように、薬剤ライブラリ情報１１２は、薬剤名と、当該薬剤の投与が行われる場所（プロファイル）と、当該薬剤の投与量のリミット値（ソフトリミット値、ハードリミット値）とが対応付けて格納されている。なお、図２の２ａの薬剤ライブラリ情報１１２に示す各項目は一例であり、これ以外の項目が格納されてもよいことはいうまでもない。 2a of FIG. 2 is a diagram illustrating an example of drug library information 112 generated by executing the drug library management software 111. FIG. As shown in 2a of FIG. 2, the drug library information 112 includes a drug name, a location (profile) where the drug is administered, a limit value (soft limit value, hard limit value) of the dose of the drug, and the like. Are stored in association with each other. It should be noted that each item shown in the drug library information 112 of 2a in FIG. 2 is an example, and it goes without saying that other items may be stored.
　１２０はクリニカルパス管理用のソフトウェア１２１がインストールされた第２の情報処理装置であり、当該第２の情報処理装置１２０において、クリニカルパス管理用のソフトウェア１２１が実行されることにより、クリニカルパス情報１２２を生成したり、生成したクリニカルパス情報１２２への新たなデータの追加、変更等を行ったりすることができる。 Reference numeral 120 denotes a second information processing apparatus in which clinical path management software 121 is installed. When the clinical path management software 121 is executed in the second information processing apparatus 120, the clinical path information 122 is displayed. Can be generated, or new data can be added to or changed from the generated clinical path information 122.
　なお、クリニカルパスとは、入院時に患者に手渡される診療スケジュール表であり、疾病を治すうえで必要な医療行為の内容（治療項目、検査項目、ケア項目など）を縦軸にとり、時間軸（日付）を横軸にとった表である。図２の２ｂは、クリニカルパス管理用のソフトウェア１２１が実行されることにより生成されたクリニカルパス情報の一例を示す図である。 The clinical path is a medical treatment schedule handed to the patient at the time of admission. The vertical axis indicates the content of medical actions (treatment items, test items, care items, etc.) necessary to cure the disease, and the time axis (date ) On the horizontal axis. 2b of FIG. 2 is a diagram illustrating an example of clinical path information generated by executing the clinical path management software 121.
　図２の２ｂに示すように、クリニカルパス情報１２２には、それぞれのクリニカルパスを識別するためのパスＩＤ（識別子）と、各クリニカルパスにおいて各治療段階（“ステージ１”、“ステージ２”）で患者に対して行われる医療行為（“検査”、“手術”）や、各医療行為を行う際に使用が禁止されている薬剤（使用禁止薬剤）、あるいは使用は認められているが送液する際のリミット値が厳しく制限されている薬剤（制限薬剤）またはそのリミット値といった医療行為に関する情報が対応付けて格納されている。 As shown in 2b of FIG. 2, the clinical path information 122 includes a path ID (identifier) for identifying each clinical path and each treatment stage (“stage 1”, “stage 2”) in each clinical path. Medical treatments ("inspection", "surgery") performed on patients in Japan, drugs that are prohibited for use in performing each medical practice (prohibited drugs), or use is permitted but liquid delivery Information relating to medical practice such as a drug (restricted drug) whose limit value is strictly limited or its limit value is stored in association with each other.
　１３０は患者管理用のソフトウェア１３１がインストールされた第３の情報処理装置であり、当該第３の情報処理装置１３０において、患者管理用のソフトウェア１３１が実行されることにより、患者情報１３２を生成したり、生成した患者情報１３２への新たなデータの追加・変更等を行ったりすることができる。 Reference numeral 130 denotes a third information processing apparatus in which the patient management software 131 is installed. The patient information 132 is generated by executing the patient management software 131 in the third information processing apparatus 130. Or adding / changing new data to the generated patient information 132.
　図２の２ｃは、患者管理用のソフトウェア１３１が実行されることにより生成された患者情報１３２の一例を示す図である。図２の２ｃに示すように、患者情報１３２には、患者名と、当該患者の疾病名、当該患者に適用されるクリニカルパスのパスＩＤ、当該患者の現在の治療段階等が対応付けて格納されている。 2c of FIG. 2 is a diagram illustrating an example of patient information 132 generated by executing the patient management software 131. As shown in 2c of FIG. 2, the patient information 132 stores the patient name, the disease name of the patient, the path ID of the clinical path applied to the patient, the current treatment stage of the patient, and the like in association with each other. Has been.
　１４０はシリンジポンプであり、シリンジに装填された薬剤を、設定された送液量で患者の体内に送液する。１５０は移動端末であり、患者情報や治療・検査に用いられる送液ポンプ等の各種医療機器に関する情報を取得し、アクセスポイント１６０を介してネットワーク１７０に送信する。 140 is a syringe pump, which feeds the medicine loaded in the syringe into the patient's body with a set amount of liquid to be fed. Reference numeral 150 denotes a mobile terminal that acquires patient information and information related to various medical devices such as a liquid feed pump used for treatment / examination, and transmits the information to the network 170 via the access point 160.
　なお、第１乃至第３の情報処理装置（１１０、１２０、１３０）及びシリンジポンプ１４０、アクセスポイント１６０は、互いにネットワーク１７０を介して接続されているものとする。これにより、例えば、移動端末１５０において取得された患者情報や各種医療機器に関する情報を、第１乃至第３の情報処理装置（１１０、１２０、１３０）に送信したり、第１乃至第３の情報処理装置（１１０、１２０、１３０）に格納されている各種情報をシリンジポンプ１４０に送信したりすることができる。 It is assumed that the first to third information processing devices (110, 120, 130), the syringe pump 140, and the access point 160 are connected to each other via the network 170. Thereby, for example, patient information acquired in the mobile terminal 150 and information on various medical devices are transmitted to the first to third information processing devices (110, 120, 130), or the first to third information. Various types of information stored in the processing devices (110, 120, 130) can be transmitted to the syringe pump 140.
　＜２．ネットワークシステムにおける処理の流れ＞
　次に、ネットワークシステム１００における処理の流れについて説明する。図３Ａ、図３Ｂはネットワークシステム１００における処理の流れを示すシーケンス図である。 <2. Process flow in network system>
Next, a processing flow in the network system 100 will be described. 3A and 3B are sequence diagrams showing a flow of processing in the network system 100. FIG.
　図３Ａ、図３Ｂに示すように、ステップＳ３３１では、クリニカルパス管理用ソフトウェア１２１が実行されることにより、各患者のクリニカルパスが生成され、クリニカルパス情報１２２として登録される。ステップＳ３３２では、ステップＳ３３１において各患者について生成された複数のクリニカルパスを含むクリニカルパス情報１２２をシリンジポンプ１４０に送信する。 3A and 3B, in step S331, the clinical path management software 121 is executed to generate a clinical path for each patient and register it as clinical path information 122. In step S332, the clinical path information 122 including a plurality of clinical paths generated for each patient in step S331 is transmitted to the syringe pump 140.
　クリニカルパス情報１２２が送信されたシリンジポンプ１４０では、ステップＳ３５１において、当該クリニカルパス情報１２２を受信し、内部の記憶装置に格納する。 In step S351, the syringe pump 140 to which the clinical path information 122 has been transmitted receives the clinical path information 122 and stores it in the internal storage device.
　同様に、ステップＳ３４１では、薬剤ライブラリ管理用ソフトウェア１１１が実行されることにより、薬剤ライブラリ情報１１２が生成される。ステップＳ３４２では、ステップＳ３４１において生成された薬剤ライブラリ情報１１２をシリンジポンプ１４０に送信する。 Similarly, in step S341, drug library information 112 is generated by executing the drug library management software 111. In step S342, the medicine library information 112 generated in step S341 is transmitted to the syringe pump 140.
　薬剤ライブラリ情報１１２が送信されたシリンジポンプ１４０では、ステップＳ３５２において、当該薬剤ライブラリ情報１１２を受信し、内部の記憶装置に格納する。このようにして、シリンジポンプ１４０には、クリニカルパス情報１２２と薬剤ライブラリ情報１１２とが格納されることとなる。 In step S352, the syringe pump 140 to which the drug library information 112 is transmitted receives the drug library information 112 and stores it in the internal storage device. In this manner, the clinical path information 122 and the drug library information 112 are stored in the syringe pump 140.
　このような状況下で、ネットワークシステム１００を利用して、所定の患者に対して、現在適用されているクリニカルパスにおける現在の治療段階に適した薬剤の投与を行う場合について説明する。この場合、看護師等は、まず、移動端末１５０を用いて各種情報を入力する。 Under such circumstances, a case will be described in which the network system 100 is used to administer a drug suitable for the current treatment stage in the currently applied clinical path to a predetermined patient. In this case, the nurse or the like first inputs various information using the mobile terminal 150.
　具体的には、ステップＳ３０１において、薬剤の投与を行う患者の患者情報を入力する。なお、患者情報の入力は、移動端末１５０に対して、看護師等が手入力するようにしてもよいし、患者に取り付けられたタグ（患者を識別するために、患者情報が記録されたタグ）を読み取るようにしてもよい。 Specifically, in step S301, patient information of a patient who administers a drug is input. The patient information may be input manually by a nurse or the like to the mobile terminal 150, or a tag attached to the patient (a tag on which patient information is recorded to identify the patient). ) May be read.
　ステップＳ３０２では、薬剤の投与に用いられる医療機器に関する情報を入力する。なお、医療機器情報の入力は、患者情報の入力と同様、移動端末１５０に対して、看護師等が手入力するようにしてもよいし、医療機器に取り付けられたバーコード（医療機器を識別するための機器情報を示すバーコード）を移動端末１５０が読み取るようにしてもよい。 In step S302, information related to a medical device used for drug administration is input. Note that the medical device information may be input manually by a nurse or the like to the mobile terminal 150 in the same manner as the patient information input, or a barcode (identified medical device) attached to the medical device. The mobile terminal 150 may read a bar code indicating device information to be used).
　ステップＳ３０３では、移動端末１５０に対して、看護師等により送信指示が入力されることで、ステップＳ３０１において入力された患者情報と、ステップＳ３０２において入力された医療機器情報とが、ネットワーク１７０を介して、第３の情報処理装置１３０に送信される。 In step S303, when a nurse or the like inputs a transmission instruction to the mobile terminal 150, the patient information input in step S301 and the medical device information input in step S302 are transmitted via the network 170. And transmitted to the third information processing apparatus 130.
　患者情報と医療機器情報とを受信した第３の情報処理装置１３０では、ステップＳ３１１において、パスＩＤと治療段階情報とを取得する。具体的には、患者情報１３２の中から、受信した患者情報に対応するパスＩＤと治療段階情報とを取得する。 In the third information processing apparatus 130 that has received the patient information and the medical device information, the path ID and the treatment stage information are acquired in step S311. Specifically, a path ID and treatment stage information corresponding to the received patient information are acquired from the patient information 132.
　更に、ステップＳ３１２において、受信した医療機器情報に対応する医療機器（本実施形態では、シリンジポンプ１４０）を特定し、当該特定した医療機器に対して、ステップＳ３１１において取得したパスＩＤと治療段階情報とを送信する。 Further, in step S312, a medical device (syringe pump 140 in the present embodiment) corresponding to the received medical device information is specified, and the path ID and treatment stage information acquired in step S311 for the specified medical device. And send.
　パスＩＤと治療段階情報とを受信したシリンジポンプ１４０では、ステップＳ３５３において誤操作防止処理を実行する。 In the syringe pump 140 that has received the path ID and the treatment stage information, an erroneous operation prevention process is executed in step S353.
　以降、ネットワークシステム１００では、第１の情報処理装置１１０において薬剤ライブラリ情報が更新されるごとに、更新後の薬剤ライブラリ情報がシリンジポンプ１４０に送信され、シリンジポンプ１４０に格納された薬剤ライブラリ情報が更新される。同様に、第２の情報処理装置１２０においてクリニカルパス情報が更新されるごとに、更新後のクリニカルパス情報がシリンジポンプ１４０に送信され、シリンジポンプ１４０に格納されたクリニカルパス情報が更新される。 Thereafter, in the network system 100, each time the drug library information is updated in the first information processing apparatus 110, the updated drug library information is transmitted to the syringe pump 140, and the drug library information stored in the syringe pump 140 is updated. Updated. Similarly, every time the clinical path information is updated in the second information processing apparatus 120, the updated clinical path information is transmitted to the syringe pump 140, and the clinical path information stored in the syringe pump 140 is updated.
　また、シリンジポンプ１４０を用いて患者に対して薬剤の投与を行うたびに、事前に、移動端末１５０を用いて取得された当該患者の患者情報及びシリンジポンプ１４０を示す医療機器情報が第３の情報処理装置１３０に送信され、シリンジポンプ１４０に対しては、当該患者に対応するパスＩＤ及び治療段階情報が送信される。この結果、シリンジポンプ１４０では、当該患者の治療段階に適した誤動作防止処理を実行することが可能となる。なお、シリンジポンプ１４０における誤動作防止処理の詳細は後述する。 In addition, every time a medicine is administered to a patient using the syringe pump 140, the patient information of the patient acquired using the mobile terminal 150 and the medical device information indicating the syringe pump 140 are stored in advance in the third state. It is transmitted to the information processing apparatus 130, and the path ID and treatment stage information corresponding to the patient are transmitted to the syringe pump 140. As a result, the syringe pump 140 can execute a malfunction prevention process suitable for the patient's treatment stage. Details of the malfunction prevention process in the syringe pump 140 will be described later.
　＜３．シリンジポンプの機能構成＞
　次に、本実施形態におけるシリンジポンプ１４０の構成について説明する。図４は、シリンジポンプ１４０の構成を示す図である。 <3. Functional configuration of syringe pump>
Next, the structure of the syringe pump 140 in this embodiment is demonstrated. FIG. 4 is a diagram illustrating the configuration of the syringe pump 140.
　図４において、４０１は制御部であり、シリンジポンプ１４０全体を制御する。４０２はメモリであり、制御部４０１において各種プログラムが実行される際の作業領域として機能するとともに、各種プログラムが実行される際に用いられるデータの一時記憶領域として機能する。 In FIG. 4, 401 is a control part, and controls the syringe pump 140 whole. A memory 402 functions as a work area when various programs are executed in the control unit 401 and also functions as a temporary storage area for data used when various programs are executed.
　４０３は記憶装置であり、薬剤を送液する送液制御機能を実現するためのプログラム４１１の他、後述する誤操作防止機能を実現するためのプログラム４１２が格納されている。また、第１の情報処理装置１１０より送信された薬剤ライブラリ情報１１２と、第２の情報処理装置１２０より送信されたクリニカルパス情報１２２が格納されている。 Reference numeral 403 denotes a storage device, which stores a program 412 for realizing an erroneous operation preventing function described later, in addition to a program 411 for realizing a liquid feeding control function for feeding a medicine. Further, the medicine library information 112 transmitted from the first information processing apparatus 110 and the clinical path information 122 transmitted from the second information processing apparatus 120 are stored.
　なお、送液制御機能を実現するためのプログラム４１１及び誤操作防止機能を実現するためのプログラム４１２、ならびに、薬剤ライブラリ情報１１２及びクリニカルパス情報１２２は、制御部４０１による制御のもと、適宜メモリ４０２に読み込まれ、制御部４０１によって実行または処理されるものとする。 The program 411 for realizing the liquid feeding control function, the program 412 for realizing the erroneous operation prevention function, the drug library information 112 and the clinical path information 122 are appropriately stored in the memory 402 under the control of the control unit 401. , And executed or processed by the control unit 401.
　４０４は操作部であり、シリンジポンプ１４０に対する各種指示を入力する。４０５は表示部であり、制御部４０１における処理結果を表示する。４０６は駆動制御部であり、薬剤を送液する駆動部４０７の動作を制御する。 404 is an operation unit for inputting various instructions to the syringe pump 140. Reference numeral 405 denotes a display unit that displays a processing result in the control unit 401. Reference numeral 406 denotes a drive control unit that controls the operation of the drive unit 407 for feeding a medicine.
　４０８はネットワークＩ／Ｆ部であり、シリンジポンプ１４０は、当該ネットワークＩ／Ｆ部４０８を有することにより、ネットワーク１７０と接続可能となっている。上述した薬剤ライブラリ情報１１２及びクリニカルパス情報１２２は、第１の情報処理装置１１０または第２の情報処理装置１２０より、当該ネットワークＩ／Ｆ部４０８を介して受信される。 408 is a network I / F unit, and the syringe pump 140 can be connected to the network 170 by including the network I / F unit 408. The drug library information 112 and the clinical path information 122 described above are received from the first information processing apparatus 110 or the second information processing apparatus 120 via the network I / F unit 408.
　なお、シリンジポンプ１４０を構成する各部（４０１～４０８）は、バス４０９を介して相互に接続されているものとする。 In addition, each part (401-408) which comprises the syringe pump 140 shall be mutually connected via the bus | bath 409. FIG.
　＜４．誤操作防止処理（１）の流れ＞
　次に、誤操作防止処理の流れについて説明する。シリンジポンプ１４０では、誤操作防止処理として、少なくとも２種類の誤操作防止処理を実行する。第１の誤操作防止処理は、シリンジポンプ１４０上において、送液を行う薬剤の種類を指定するための操作において、誤操作を防止する処理（誤操作防止処理（１））であり、第２の誤操作防止処理は、指定した薬剤を送液する際の送液量を設定するための操作において、誤操作を防止する処理（誤操作防止処理（２））である。 <4. Flow of erroneous operation prevention process (1)>
Next, the flow of the erroneous operation prevention process will be described. The syringe pump 140 executes at least two types of erroneous operation prevention processes as the erroneous operation prevention process. The first erroneous operation prevention process is a process for preventing an erroneous operation (an erroneous operation prevention process (1)) in the operation for designating the type of medicine to be fed on the syringe pump 140, and the second erroneous operation prevention. The process is a process for preventing an erroneous operation (erroneous operation prevention process (2)) in an operation for setting a liquid supply amount when a specified medicine is supplied.
　はじめに前者の誤操作防止処理（１）について説明する。図５は、送液を行う薬剤の種類を指定するための操作において、誤操作を防止する誤操作防止処理（１）の流れを示すフローチャートである。 First, the former erroneous operation prevention process (1) will be described. FIG. 5 is a flowchart showing the flow of an erroneous operation prevention process (1) for preventing an erroneous operation in an operation for designating the type of medicine to be delivered.
　ステップＳ５０１では、薬剤ライブラリ表示指示を受け付けたか否かを判定する。ステップＳ５０１において、薬剤ライブラリ表示指示を受け付けていないと判定された場合には、薬剤ライブラリ表示指示を受け付けるまで待機する。 In step S501, it is determined whether a medicine library display instruction has been accepted. If it is determined in step S501 that a medicine library display instruction has not been received, the process waits until a medicine library display instruction is received.
　一方、ステップＳ５０１において、薬剤ライブラリ表示指示を受け付けたと判定された場合には、ステップＳ５０２に進む。ステップＳ５０２では、薬剤ライブラリのうち、薬剤ライブラリの表示指示に際して看護師等により選択されたプロファイルに対応する薬剤ライブラリを読み出す。 On the other hand, if it is determined in step S501 that a medicine library display instruction has been received, the process proceeds to step S502. In step S502, the drug library corresponding to the profile selected by the nurse or the like when the drug library is instructed to be displayed is read from the drug library.
　ステップＳ５０３では、（ステップＳ３１２において）第３の情報処理装置１３０より送信されたパスＩＤに対応するクリニカルパスを読み出す。 In step S503, the clinical path corresponding to the path ID transmitted from the third information processing apparatus 130 is read (in step S312).
　ステップＳ５０４では、ステップＳ５０２において読み出されたクリニカルパスより、ステップＳ３１２において第３の情報処理装置１３０より送信された治療段階情報に対応する医療行為の内容に関する情報を抽出する。 In step S504, information on the content of the medical practice corresponding to the treatment stage information transmitted from the third information processing apparatus 130 in step S312 is extracted from the clinical path read in step S502.
　ここでは、クリニカルパス情報１２２より、パスＩＤが“００１”であって、治療段階情報が“ステージ１”に対応する医療行為の内容に関する情報（項目：“検査”、使用禁止薬剤：“薬剤Ａ”、制限薬剤：“薬剤Ｆ”）が抽出されたとする。 Here, from the clinical path information 122, the path ID is “001” and the treatment stage information is information related to the content of the medical practice corresponding to “stage 1” (item: “examination”, prohibited drug: “drug A”. ", Restricted drug:" drug F ") is extracted.
　ステップＳ５０５では、当該抽出した医療行為の内容に含まれる使用禁止薬剤を識別する。ここでは、使用禁止薬剤として“薬剤Ａ”が識別される。 In step S505, a prohibited drug contained in the extracted medical practice content is identified. Here, “drug A” is identified as a prohibited drug.
　ステップＳ５０６では、ステップＳ５０５において識別された使用禁止薬剤が、ステップＳ５０２において読み出された薬剤ライブラリに含まれているか否かを判定する。ステップＳ５０６において、使用禁止薬剤が、読み出された薬剤ライブラリに含まれていると判定された場合には、ステップＳ５０７に進み、当該薬剤ライブラリを表示するにあたり、使用禁止薬剤を網掛け表示にして表示する。ここでは、“薬剤Ａ”が網掛け表示となって、薬剤ライブラリが表示されることとなる。 In step S506, it is determined whether or not the prohibited drug identified in step S505 is included in the drug library read in step S502. If it is determined in step S506 that the prohibited drug is included in the read drug library, the process proceeds to step S507, and the prohibited drug is displayed in a shaded manner in displaying the drug library. indicate. Here, “medicine A” is shaded and the drug library is displayed.
　図７は、薬剤ライブラリの表示指示が入力された際に、誤操作防止処理（１）が実行されることで、“薬剤Ａ”が網掛け表示となった様子を示している。 FIG. 7 shows a state in which “medicine A” is displayed in a shaded manner by executing the erroneous operation prevention process (1) when a medicine library display instruction is input.
　一方、ステップＳ５０６において、使用禁止薬剤が薬剤ライブラリに含まれていないと判定された場合には、ステップＳ５０８に進み、ステップＳ５０２において読み出された薬剤ライブラリをそのまま表示する。 On the other hand, if it is determined in step S506 that the prohibited drug is not included in the drug library, the process proceeds to step S508, and the drug library read in step S502 is displayed as it is.
　このように、薬剤ライブラリを表示するにあたり、患者の現在の治療段階において使用禁止となっている薬剤を網掛け表示することにより、薬剤の種類の選択に際して、看護師等が誤って当該使用禁止薬剤を選択してしまうといった事態を回避することが可能となる。 In this way, when displaying a drug library, by displaying the drugs that are prohibited for use in the current treatment stage of the patient in a shaded manner, a nurse or the like erroneously selects the prohibited drugs when selecting the type of drug. It is possible to avoid a situation where the user is selected.
　＜５．誤操作防止処理（２）の流れ＞
　次に、指定した薬剤を送液する際の送液量を設定するための操作において、誤操作を防止する誤操作防止処理（２）について説明する。図６Ａ、図６Ｂは、送液量を設定するための操作において、誤操作を防止する誤操作防止処理（２）の流れを示すフローチャートである。 <5. Flow of erroneous operation prevention process (2)>
Next, a description will be given of an erroneous operation prevention process (2) for preventing an erroneous operation in an operation for setting a liquid supply amount when a designated medicine is supplied. 6A and 6B are flowcharts showing the flow of an erroneous operation prevention process (2) for preventing an erroneous operation in an operation for setting the liquid feeding amount.
　ステップＳ６０１では、薬剤ライブラリの中から看護師等が選択することにより指定された薬剤に対応するリミット値を薬剤ライブラリ情報１１２より読み出す。図２に示したように、薬剤ライブラリ情報１１２には、薬剤ごとに送液量のリミット値が規定されている。 In step S601, the limit value corresponding to the medicine specified by the nurse or the like selected from the medicine library is read from the medicine library information 112. As shown in FIG. 2, the drug library information 112 defines a limit value for the liquid supply amount for each drug.
　ステップＳ６０２では、ステップＳ６０１において読み出されたリミット値を、シリンジポンプ１４０に設定する。 In step S602, the limit value read in step S601 is set in the syringe pump 140.
　ステップＳ６０３では、ステップＳ３１２において第３の情報処理装置１３０より送信されたパスＩＤに対応するクリニカルパスを読み出す。ステップＳ６０４では、ステップＳ６０３において読み出されたクリニカルパスより、ステップＳ３１２において第３の情報処理装置１３０より送信された治療段階情報に対応する医療行為の内容を抽出する。 In step S603, the clinical path corresponding to the path ID transmitted from the third information processing apparatus 130 in step S312 is read. In step S604, the content of the medical practice corresponding to the treatment stage information transmitted from the third information processing apparatus 130 in step S312 is extracted from the clinical path read in step S603.
　ステップＳ６０５では、ステップＳ６０４において抽出された医療行為の内容に、リミット値が制限された薬剤（制限薬剤）が含まれているか否かを判定する。ステップＳ６０５において医療行為の内容に制限薬剤が含まれていると判定された場合には、ステップＳ６０６に進む。 In step S605, it is determined whether the content of the medical practice extracted in step S604 includes a drug whose limit value is limited (restricted drug). When it is determined in step S605 that the restricted medicine is included in the content of the medical practice, the process proceeds to step S606.
　ステップＳ６０６では、抽出された医療行為の内容に含まれる制限薬剤のリミット値を取得する。 In step S606, the limit value of the restricted drug included in the extracted medical practice content is acquired.
　ステップＳ６０７では、ステップＳ６０６において取得したリミット値を用いて、ステップＳ６０２において設定されたリミット値を書き換える。これにより、薬剤ライブラリ情報１１２に規定されていた薬剤ごとのリミット値よりも、治療段階に則した高度なリミット値を設定することが可能となる。 In step S607, the limit value set in step S602 is rewritten using the limit value acquired in step S606. Thereby, it is possible to set a higher limit value in accordance with the treatment stage than the limit value for each drug defined in the drug library information 112.
　一方、ステップＳ６０５において、医療行為の内容に制限薬剤が含まれていないと判定された場合には、ステップＳ６０８に進む。この場合、ステップＳ６０２において設定されたリミット値は書き換えられることなく維持される。 On the other hand, if it is determined in step S605 that the restricted medicine is not included in the content of the medical practice, the process proceeds to step S608. In this case, the limit value set in step S602 is maintained without being rewritten.
　ステップＳ６０８では、送液量設定指示が入力されたか否かを判定する。ステップＳ６０８において、送液量設定指示が入力されていないと判定された場合には、入力されるまで待機する。 In step S608, it is determined whether or not a liquid supply amount setting instruction has been input. If it is determined in step S608 that the liquid supply amount setting instruction has not been input, the process waits until it is input.
　一方、ステップＳ６０８において、送液量設定指示が入力されたと判定された場合には、ステップＳ６０９に進み、入力された送液量設定指示が、設定されたリミット値（ステップＳ６０２において設定されたリミット値、または、ステップＳ６０７において書き換えられたリミット値）の範囲内に含まれているか否かを判定する。 On the other hand, if it is determined in step S608 that the liquid supply amount setting instruction has been input, the process proceeds to step S609, and the input liquid supply amount setting instruction is set to the set limit value (the limit set in step S602). Value or the limit value rewritten in step S607).
　ステップＳ６０９において、リミット値の範囲内に含まれていると判定された場合には、ステップＳ６１０に進み、当該入力された送液量設定指示を受け付ける。一方、リミット値の範囲内に含まれていないと判定された場合には、ステップＳ６１１に進み、警報を出力する。 If it is determined in step S609 that it is included within the range of the limit value, the process proceeds to step S610, and the input liquid supply amount setting instruction is accepted. On the other hand, if it is determined that it is not included in the limit value range, the process proceeds to step S611 to output an alarm.
　以上の説明から明らかなように、本実施形態に係るシリンジポンプ１４０では、薬剤ライブラリ情報に加え、クリニカルパス情報を取得し、格納する構成とした。更に、患者に対して薬剤の送液を行う前に、当該患者に適用されているクリニカルパスを示すパスＩＤと、現在の治療段階情報とを取得し、当該患者の現在の治療段階における使用禁止薬剤や、薬剤を送液する際の送液量のリミット値を、クリニカルパスより取得する構成とした。 As apparent from the above description, the syringe pump 140 according to this embodiment is configured to acquire and store clinical path information in addition to the drug library information. Furthermore, before delivering the drug to the patient, obtain the path ID indicating the clinical path applied to the patient and the current treatment stage information, and prohibit the use of the patient at the current treatment stage. It was set as the structure which acquires the limit value of the chemical | medical agent and the liquid feeding amount at the time of liquid feeding from a clinical path.
　この結果、シリンジポンプ１４０上で、送液すべき薬剤の種類を指定すべく薬剤ライブラリを表示するにあたり、現在の治療段階における使用禁止薬剤を網掛け表示としたうえで表示させることが可能となり、看護師等が、誤って使用禁止薬剤を選択してしまうといった事態を確実に回避させることが可能となった。 As a result, when displaying the drug library on the syringe pump 140 so as to specify the type of drug to be delivered, it is possible to display the use-prohibited drug at the current treatment stage as a shaded display, It has become possible to reliably avoid such a situation that a nurse or the like selects a prohibited drug by mistake.
　また、薬剤を送液する際の送液量を設定するにあたり、現在の治療段階に対応するリミット値を設定することが可能となり、看護師等が、誤って、現在の治療段階にそぐわない送液量を設定してしまうといった事態を確実に回避させることが可能となった。 In addition, when setting the amount of liquid to be delivered, it is possible to set a limit value corresponding to the current treatment stage. It has become possible to reliably avoid situations such as setting the amount.
　［第２の実施形態］
　上記第１の実施形態では、送液ポンプとしてシリンジポンプを使用する場合について説明したが、本発明はこれに限定されず、輸液ポンプを使用する場合において同様である。 [Second Embodiment]
In the first embodiment, the case where a syringe pump is used as the liquid delivery pump has been described. However, the present invention is not limited to this, and the same applies when an infusion pump is used.
　また、上記第１の実施形態では、第１の情報処理装置１１０～第３の情報処理装置１３０をそれぞれ別体として設ける構成としたが、本発明はこれに限定されず、一体的に構成されていてもよいことは言うまでもない。 In the first embodiment, the first information processing device 110 to the third information processing device 130 are provided as separate bodies. However, the present invention is not limited to this and is configured integrally. It goes without saying that it may be.
　また、上記第１の実施形態では、第１の情報処理装置１１０において薬剤ライブラリが生成、更新されるごとに、シリンジポンプ１４０に送信される構成としたが、本発明はこれに限定されない。例えば、シリンジポンプ１４０からの要求に応じて、送信する構成としてもよい。この場合、シリンジポンプ１４０からの要求は、一定周期ごとに行うように構成してもよいし、シリンジポンプ１４０において特定の操作が行われるごとに行うように構成してもよい。 In the first embodiment, the first information processing apparatus 110 transmits the medicine library to the syringe pump 140 each time it is generated and updated. However, the present invention is not limited to this. For example, it may be configured to transmit in response to a request from the syringe pump 140. In this case, the request from the syringe pump 140 may be configured to be performed at regular intervals, or may be configured to be performed every time a specific operation is performed in the syringe pump 140.
　同様に、上記第１の実施形態では、第２の情報処理装置１２０においてクリニカルパス情報が生成、更新されるごとに、シリンジポンプ１４０に送信される構成としたが、本発明はこれに限定されない。例えば、シリンジポンプ１４０からの要求に応じて、送信する構成としてもよい。この場合、シリンジポンプ１４０からの要求は、一定周期ごとに行うように構成してもよいし、シリンジポンプ１４０において特定の操作が行われるごとに行うように構成してもよい。 Similarly, in the first embodiment, the second information processing device 120 is configured to transmit the clinical path information to the syringe pump 140 each time it is generated and updated. However, the present invention is not limited to this. . For example, it may be configured to transmit in response to a request from the syringe pump 140. In this case, the request from the syringe pump 140 may be configured to be performed at regular intervals, or may be configured to be performed every time a specific operation is performed in the syringe pump 140.
　また、上記第１の実施形態では、シリンジポンプ１４０において薬剤ライブラリ情報を表示するにあたり、使用禁止薬剤を網掛け表示にする構成としたが、本発明はこれに限定されない。例えば、使用禁止薬剤に非表示にする構成としてもよいし、（表示は行うが）使用禁止薬剤を選択できないように構成してもよい。 In the first embodiment, when displaying the drug library information in the syringe pump 140, the prohibited drug is displayed in a shaded manner. However, the present invention is not limited to this. For example, it may be configured not to be displayed on the prohibited drug, or may be configured so that the prohibited drug cannot be selected (although it is displayed).
　また、上記第１の実施形態では、シリンジポンプ１４０において薬剤の送液量を設定するにあたり、リミット値の範囲外となった場合に警報を出力する構成としたが、本発明はこれに限定されない。例えば、リミット値を超える設定ができないように、操作上の制限を付加するように構成してもよい。 Further, in the first embodiment, in setting the amount of medicine to be fed in the syringe pump 140, an alarm is output when the amount is outside the limit value range, but the present invention is not limited to this. . For example, an operational restriction may be added so that setting exceeding the limit value cannot be performed.
　また、上記第１の実施形態では、シリンジポンプ１４０において薬剤の送液量を設定する場合の制御について説明したが、本発明はこれに限定されず、送液量以外の設定についても、同様にクリニカルパスに基づいて制御するように構成してもよい。 In the first embodiment, the control in the case of setting the liquid delivery amount of the medicine in the syringe pump 140 has been described. However, the present invention is not limited to this, and the same applies to settings other than the liquid delivery amount. You may comprise so that it may control based on a clinical path.
　また、上記第１の実施形態では、送液を行う薬剤の種類を指定するための操作においては、誤操作防止処理（１）が実行され、送液量を設定するための操作においては、誤操作防止処理（２）が実行される構成としたが、本発明はこれに限定されず、いずれか一方の誤操作防止処理のみが実行されるように構成してもよい。 Further, in the first embodiment, the erroneous operation prevention process (1) is executed in the operation for designating the type of medicine to be delivered, and the erroneous operation is prevented in the operation for setting the liquid delivery amount. Although the process (2) is configured to be executed, the present invention is not limited to this, and only one of the erroneous operation prevention processes may be executed.
　また、上記第１の実施形態では、誤操作防止処理（１）と誤操作防止処理（２）とを個別に実行させる構成としたが、本発明はこれに限定されず、並行して実行させるように構成してもよい。この場合、共通する処理については１回のみ実行させることで、シリンジポンプ１４０の処理負荷を軽減させることが可能となる。 In the first embodiment, the erroneous operation prevention process (1) and the erroneous operation prevention process (2) are separately executed. However, the present invention is not limited to this and is executed in parallel. It may be configured. In this case, the processing load of the syringe pump 140 can be reduced by executing the common processing only once.
　本発明は上記実施の形態に制限されるものではなく、本発明の精神及び範囲から離脱することなく、様々な変更及び変形が可能である。従って、本発明の範囲を公にするために、以下の請求項を添付する。 The present invention is not limited to the above embodiment, and various changes and modifications can be made without departing from the spirit and scope of the present invention. Therefore, in order to make the scope of the present invention public, the following claims are attached.
　本願は、２０１２年２月２７日提出の日本国特許出願特願２０１２－０４０６４０を基礎として優先権を主張するものであり、その記載内容の全てを、ここに援用する。 This application claims priority on the basis of Japanese Patent Application No. 2012-040640 filed on Feb. 27, 2012, the entire contents of which are incorporated herein by reference.

Claims (7)

  1. 　患者に対して薬剤の送液を行う、ネットワークに接続可能な送液ポンプであって、
    　各疾病に応じた複数の診療スケジュールを記憶する記憶手段と、
    　送液を行う患者に現在適用されている診療スケジュールを示す識別子と、該診療スケジュールにおける各治療段階のうち、該送液を行う患者の現在の治療段階を示す情報とを、前記ネットワークを介して受信する受信手段と、
    　前記識別子により特定された診療スケジュールに含まれる、前記治療段階を示す情報に対応する治療段階における医療行為の内容を、前記記憶手段に記憶されている診療スケジュールより取得する取得手段と、
    　前記取得された医療行為の内容に含まれる、薬剤の送液に関する情報を抽出する抽出手段と、
    　前記抽出手段により抽出された前記薬剤の送液に関する情報に基づいて、前記送液ポンプを制御する制御手段と
    　を備えることを特徴とする送液ポンプ。     A fluid delivery pump that can connect to a network and deliver medication to patients.
    Storage means for storing a plurality of medical treatment schedules corresponding to each disease;
    An identifier indicating a medical treatment schedule currently applied to a patient who performs liquid feeding, and information indicating a current medical treatment stage of the patient performing the liquid feeding among the treatment stages in the medical treatment schedule via the network. Receiving means for receiving;
    An acquisition means for acquiring, from the medical treatment schedule stored in the storage means, the content of the medical treatment in the treatment stage corresponding to the information indicating the treatment stage included in the medical treatment schedule specified by the identifier;
    An extraction means for extracting information relating to the liquid delivery of the medicine included in the content of the acquired medical practice;
    A liquid feed pump comprising: control means for controlling the liquid feed pump based on information relating to the liquid feed of the medicine extracted by the extraction means.
  2. 　前記記憶手段は、更に、種々の薬剤に関する情報である薬剤ライブラリ情報を記憶しており、
    　前記制御手段は、前記記憶手段により記憶された前記薬剤ライブラリ情報を表示するにあたり、前記抽出手段により抽出された前記薬剤の送液に関する情報において、送液が禁止されている薬剤が含まれている場合には、当該送液が禁止されている薬剤が網掛け表示または非表示となるように表示を制御することを特徴とする請求項１に記載の送液ポンプ。     The storage means further stores drug library information that is information on various drugs,
    When the control means displays the medicine library information stored in the storage means, the information on the liquid delivery of the medicine extracted by the extraction means includes a medicine for which liquid feeding is prohibited. In the case, the liquid feed pump according to claim 1, wherein the display is controlled so that the medicine for which the liquid feed is prohibited is displayed in a shaded manner or not.
  3. 　前記制御手段は、送液量の設定に際して、前記抽出手段により抽出された前記薬剤の送液に関する情報において、送液量のリミット値が規定されている場合には、当該リミット値を超える送液量が入力された場合に、警報を出力するよう制御することを特徴とする請求項１または２に記載の送液ポンプ。 When the liquid supply amount is set, when the liquid supply amount limit value is defined in the information related to the liquid supply of the medicine extracted by the extraction unit when the liquid supply amount is set, the liquid supply amount exceeds the limit value. 3. The liquid feeding pump according to claim 1, wherein an alarm is output when an amount is inputted.
  4. 　前記診療スケジュールは、クリニカルパスであることを特徴とする請求項１乃至３のいずれか１項に記載の送液ポンプ。 The liquid delivery pump according to any one of claims 1 to 3, wherein the medical treatment schedule is a clinical path.
  5. 　請求項１乃至４のいずれか１項に記載の送液ポンプと、
    　患者ごとに現在適用されている診療スケジュールと、該診療スケジュールにおける各治療段階のうち、各患者の現在の治療段階を示す情報とを管理する情報処理装置と、
    　が前記ネットワークを介して接続されるネットワークシステムであって、
    　前記情報処理装置は、送液を行う患者に関する情報と、該患者に対して薬剤を送液する際に用いる送液ポンプに関する情報が入力された場合に、該送液ポンプに対して、該患者に現在適用されている診療スケジュールを示す識別子と、該診療スケジュールにおける各治療段階のうち、該患者の現在の治療段階を示す情報とを、前記ネットワークを介して送信する送信手段を備えることを特徴とするネットワークシステム。     The liquid feed pump according to any one of claims 1 to 4,
    An information processing apparatus that manages a medical treatment schedule currently applied to each patient and information indicating a current medical treatment stage of each patient among the treatment stages in the medical treatment schedule;
    Is a network system connected via the network,
    The information processing apparatus is configured to input information about a patient who performs liquid feeding and information about a liquid feeding pump used when liquid medicine is fed to the patient to the liquid feeding pump. A transmission means for transmitting, via the network, an identifier indicating a medical treatment schedule currently applied to the information and information indicating a current medical treatment stage of the patient among the treatment stages in the medical treatment schedule. Network system.
  6. 　前記送液を行う患者に関する情報と、該患者に対して薬剤を送液する際に用いる送液ポンプに関する情報を指定する移動端末を更に備え、
    　前記情報処理装置は、前記ネットワークを介して前記移動端末より送信された場合に、前記送液を行う患者に関する情報と、該患者に対して薬剤を送液する際に用いる送液ポンプに関する情報を入力することを特徴とする請求項５に記載のネットワークシステム。     A mobile terminal for designating information related to the patient performing liquid feeding and information relating to a liquid feeding pump used when liquid medicine is delivered to the patient;
    The information processing device, when transmitted from the mobile terminal via the network, information on a patient who performs the liquid feeding and information on a liquid feeding pump used when feeding a medicine to the patient 6. The network system according to claim 5, wherein an input is performed.
  7. 　前記送液ポンプの記憶手段は、前記ネットワークを介して送信される、前記診療スケジュールを記憶することを特徴とする請求項５に記載のネットワークシステム。 6. The network system according to claim 5, wherein the storage means of the liquid feeding pump stores the medical treatment schedule transmitted via the network.
PCT/JP2013/001090 2012-02-27 2013-02-26 Fluidic pump and network system WO2013128886A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012-040640 2012-02-27
JP2012040640A JP2015091280A (en) 2012-02-27 2012-02-27 Liquid feed pump and network system

Publications (1)

Publication Number Publication Date
WO2013128886A1 true WO2013128886A1 (en) 2013-09-06

Family

ID=49082099

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/001090 WO2013128886A1 (en) 2012-02-27 2013-02-26 Fluidic pump and network system

Country Status (2)

Country Link
JP (1) JP2015091280A (en)
WO (1) WO2013128886A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6811665B2 (en) * 2017-03-28 2021-01-13 テルモ株式会社 Liquid feed pump and liquid feed system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005284855A (en) * 2004-03-30 2005-10-13 Terumo Corp Medicine administration routing apparatus, control method for the same, use history management system, use history management method, and computer program
JP2008535634A (en) * 2005-04-11 2008-09-04 ホスピラ・インコーポレイテツド Improved user interface for medical devices

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005284855A (en) * 2004-03-30 2005-10-13 Terumo Corp Medicine administration routing apparatus, control method for the same, use history management system, use history management method, and computer program
JP2008535634A (en) * 2005-04-11 2008-09-04 ホスピラ・インコーポレイテツド Improved user interface for medical devices

Also Published As

Publication number Publication date
JP2015091280A (en) 2015-05-14

Similar Documents

Publication Publication Date Title
JP6972077B2 (en) Infusion systems and pumps with configurable closed-loop delivery rate catch-up
US11868161B2 (en) Synchronized display of screen content on networked devices
US10850024B2 (en) Infusion system, device, and method having advanced infusion features
US11605468B2 (en) Infusion pump system and method with multiple drug library editor source capability
JP5864661B2 (en) Medical pump programming using electronic standing order templates
JP5485414B2 (en) System and method for administering a drug to a patient
CN107683152A (en) The programming based on flow for infusion pump
KR20150113077A (en) Medication safety devices and methods
JP2019048232A (en) Patient care device-specific configuration output
CN109147901A (en) Intelligent drug controller dosage auditing system
WO2013128886A1 (en) Fluidic pump and network system
KR101788031B1 (en) System and method for injecting drug, and drug injection device for executing the same
WO2013128907A1 (en) Information processing device and network system
CN113730715B (en) Remote anesthesia auxiliary control method and device, electronic equipment and storage medium
JP2019129853A (en) Medical pump system and medical pump
WO2014049658A1 (en) Fluid delivery device, fluid delivery system, and control method for fluid delivery device
EP3148611B1 (en) Infusion system and pump with configurable closed loop delivery rate catch-up
WO2014162487A1 (en) Medical-information management device, medical-information management system, and method for controlling medical-information management device
NZ788803A (en) Synchronized display of screen content on networked devices
NZ752330A (en) Infusion system, device, and method having advanced infusion features

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13754179

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13754179

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP